Protease-activated receptor-2 activates NQO-1 via Nrf2 stabilization in keratinocytes

Journal of Dermatological Science

Volumn 74, Issue 1, 2014, Pages 48-55

  Kim, Ji Young ^a   Kim, Do Young ^a   Son, Hyojung ^a   Kim, Yoon Jee ^a   Oh, Sang Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Keratinocyte; NF E2 related factor 2; Protease activated receptor 2; Vitiligo

Indexed keywords

NQO 1 PROTEIN; PROTEINASE ACTIVATED RECEPTOR 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; HYDROGEN PEROXIDE; NFE2L2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CELL CULTURE; CELL LEVEL; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BIOPSY; VITILIGO; WESTERN BLOTTING; ACTIVE TRANSPORT; CHEMISTRY; CYTOLOGY; ENZYME ACTIVATION; ENZYMOLOGY; EPIDERMIS; GENE SILENCING; HOMEOSTASIS; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; SKIN; TIME; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIOXIDANTS; CELL LINE, TUMOR; ENZYME ACTIVATION; EPIDERMIS; GENE SILENCING; HOMEOSTASIS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; KERATINOCYTES; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RECEPTOR, PAR-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKIN; TIME FACTORS; ULTRAVIOLET RAYS; VITILIGO;

EID: 84895923115     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.11.010     Document Type: Article

References (40)

1. Hollenberg M.D., Oikonomopoulou K., Hansen K.K., Saifeddine M., Ramachandran R., Diamandis E.P. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol Chem 2008, 389:643-651.
2. Lee S.E., Jeong S.K., Lee S.H. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J 2010, 51:808-822.
3. Rattenholl A., Steinhoff M. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease. Drug News Perspect 2008, 21:369-381.
4. Buddenkotte J., Stroh C., Engels I.H., Moormann C., Shpacovitch V.M., Seeliger S., et al. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. J Invest Dermatol 2005, 124:38-45.
5. Hou L., Kapas S., Cruchley A.T., Macey M.G., Harriott P., Chinni C., et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 1998, 94:356-362.
6. Steinhoff M., Corvera C.U., Thoma M.S., Kong W., McAlpine B.E., Caughey G.H., et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999, 8:282-294.
7. Jeong S.K., Kim H.J., Youm J.K., Ahn S.K., Choi E.H., Sohn M.H., et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008, 128:1930-1939.
8. Briot A., Lacroix M., Robin A., Steinhoff M., Deraison C., Hovnanian A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010, 130:2736-2742.
9. Lee S.E., Kim J.M., Jeong S.K., Jeon J.E., Yoon H.J., Jeong M.K., et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res 2010, 302:745-756.
10. Banfi C., Brioschi M., Barbieri S.S., et al. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells. J Thromb Haemost 2009, 7:206-216.
11. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
12. Gruber F., Mayer H., Lengauer B., Mlitz V., Sanders J.M., Kadl A., et al. NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells. FASEB J 2010, 24:39-48.
13. Schafer M., Dutsch S., auf dem Keller U., Werner S. Nrf2: a central regulator of UV protection in the epidermis. Cell Cycle 2010, 9:2917-2918.
14. Kovacs D., Raffa S., Flori E., Aspite N., Briganti S., Cardinali G., et al. Keratinocyte growth factor down-regulates intracellular ROS production induced by UVB. J Dermatol Sci 2009, 54:106-113.
15. Passi S., Grandinetti M., Maggio F., Stancato A., De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998, 11:81-85.
16. Natarajan V.T., Singh A., Kumar A.A., Sharma P., Kar H.K., Marrot L., et al. Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris. J Invest Dermatol 2010, 130:2781-2789.
17. Guan C.P., Wei X.D., Chen H.Y., Zhang L., Zhou M.N., Xu A.E. Abnormal nuclear translocation of nuclear factor-E2 related factor 2 in the lesion of vitiligo. Zhonghua Yi Xue Za Zhi 2008, 88:2403-2406.
18. Moretti S., Nassini R., Prignano F., Pacini A., Materazzi S., Naldini A., et al. Protease-activated receptor-2 downregulation is associated to vitiligo lesions. Pigment Cell Melanoma Res 2009, 22:335-338.
19. Oh S.H., Kim J.Y., Kim M.R., Do J.E., Shin J.Y., Hann S.K. DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo. J Dermatol Sci 2012, 66:163-165.
20. Ishikawa C., Tsuda T., Konishi H., Nakagawa N., Yamanishi K. Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 2009, 53:1760-1765.
21. Seiberg M., Paine C., Sharlow E., Andrade-Gordon P., Costanzo M., Eisinger M., et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000, 254:25-32.
22. Kawabata A. PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2002, 4:1-17.
23. Ossovskaya V.S., Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004, 84:579-621.
24. Shpacovitch V., Feld M., Bunnett N.W., Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007, 28:541-550.
25. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009, 284:13291-13295.
26. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86.
27. Kwak M.K., Wakabayashi N., Kensler T.W. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat Res 2004, 555:133-148.
28. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139.
29. Dinkova Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 2002, 99:11908-11913.
30. Fyfe M., Bergstrom M., Aspengren S., Peterson A. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways. Cytokine 2005, 31:358-367.
31. Kanke T., Macfarlane S.R., Seatter M.J., Davenport E., Paul A., McKenzie R.C., et al. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol Chem 2001, 276:31657-31666.
32. 2+ current by protease-activated receptor 2 activation contributes to augmentation of spontaneous uterine contractility in pregnant rats. Biochem Biophys Res Commun 2012, 418:167-172.
33. Flier J., Van Muiswinkel F.L., Jongenelen C.A., Drukarch B. The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res 2002, 36:695-699.
34. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004, 101:3381-3386.
35. Yuan X., Xu C., Pan Z., Keum Y.S., Kim J.H., Shen G., et al. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog 2006, 45:841-850.
36. Marrot L., Jones C., Perez P., Meunier J.R. The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis. Pigment Cell Melanoma Res 2008, 21:79-88.
37. Haarmann-Stemmann T., Abel J., Fritsche E., Krutmann J. The AhR-Nrf2 pathway in keratinocytes: on the road to chemoprevention. J Invest Dermatol 2012, 132:7-9.
38. Tsuji G., Takahara M., Uchi H., Matsuda T., Chiba T., Takeuchi S., et al. Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effect. J Invest Dermatol 2012, 132:59-68.
39. Kim Y.S., Zhuang H., Koehler R.C., Dore S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic Biol Med 2005, 38:85-92.
40. Guan C.P., Zhou M.N., Xu A.E., Kang K.F., Liu J.F., Wei X.D., et al. The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population. Exp Dermatol 2008, 17:1059-1062.